Mumbai - June 14, 2013 - Merial, the animal health division of Sanofi, today announced the approval and closing of Merial’s acquisition of the animal health division of Dosch Pharmaceuticals Private Limited, creating for Merial a market entry in India’s growing animal health market.
The signing of a binding agreement leading up to the acquisition was announced in December 2012. Merial and Dosch have now completed all regulatory approvals required for the closing of the acquisition.
The acquired business, now the animal health division of Sanofi Synthelabo India, will commence marketing Dosch’s 86 animal health products and 50 brands for ruminants, poultry and companion animals, as well as continue the process of registering Merial brands for companion and production animals for commercialization in India.
Dosch animal health division CEO, Dr. Sharat Tugnait, and his management team will continue to oversee the combined Merial/Dosch operations in Mumbai, India, under the executive direction of Merial India country manager, Mayank Parekh.
Merial, a Sanofi company is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,600 people and operates in more than 150 countries worldwide. Its 2012 sales were €2.2 billion ($2.8 billion). For more information, please see www.merial.com.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Contact: SANOFI INDIA
|Aparna Thomas||Ruchita Mehra|
|Senior Director-Communications & Public Affairs||Head-External Communications|
|Tel: 022-28278169||Tel: 022-28278233|
|Email: email@example.com||Email: firstname.lastname@example.org|